Rule 351-4-.07 - Packaging and Labeling(1) A production licensee shall submit drafts of the packaging and labeling designs to the Commission for approval prior to using such designs for the product. The Commission hereby delegates the authority and responsibility to review packaging and labeling designs as set forth in Code Section 16-12-203(6), and determine whether such designs shall be approved to the GMCC Executive Director. The licensee shall not use such designs unless they have been approved by the GMCC Executive Director.(2) A production licensee shall package product in final packaged form on such licensee's premises. Packaging used to contain product shall:(a) Protect the product from contamination and shall not expose the product to any toxic or harmful substance;(b) Be tamper-evident or have tamper-evident features applied to such packaging;(d) Not imitate any packaging used for goods that are publicly known to be marketed to minors;(e) Not include the following so as to attract or market to minors:1. Any cartoon, comic drawing, a series of drawings, or animation;2. Words such as "candy" or "candies" or any alternative spelling of such words; and3. Depictions of people or animals.(f) Use only Commission-approved trademarks, logos, or imagery;(g) Be a child-resistant package; and(h) Be resealable if the product has more than one (1) dose.(3) A production licensee shall label product in final packaged form on such licensee's premises. Labeling used shall be weather resistant, unobstructed, and legible, and include the following:(a) The name and license number of the production licensee;(b) The brand name of the product;(c) The unique identifying manufactured batch number of the product;(d) The registration number of the independent laboratory who completed the required testing;(f) The quantity contained therein;(g) The weight of the product in grams;(h) A list of all active ingredients, including: 1. Tetrahydrocannabinol (THC);2. Tetrahydrocannabinol acid (THCA);4. Cannabidiolic acid (CBDA); and5. Any other active ingredient that constitutes at least one percent (1%) of the cannabis used in the product.(i) The American Society for Testing and Materials International Intoxicating Cannabinoid Product Symbol standard (D8441/D8441M) universal symbol, or other symbol requirements for labeling, if designated by the Commission, indicating that products contain intoxicating cannabinoids; and(j) A statement that the product, in final packaged form, has been tested by an independent laboratory.(4) Before any product is transported to a dispensary or pharmacy, a production licensee shall package and label such product in accordance with this rule.Ga. Comp. R. & Regs. R. 351-4-.07
O.C.G.A. §§ 16-12-203, 16-12-206, 16-12-210, 16-12-211, 16-12-212.
Original Rule entitled "Packaging and Labeling" adopted. F. Mar. 16, 2023; eff. Apr. 5, 2023.Amended: F. Nov. 9, 2023; eff. Nov. 29, 2023.